dosage and administration of anti-c5 antibodies for the treatment of patients with membranoproliferative glomerulonephritis

• 1. 抗C5抗体治疗患有膜增生性肾小球肾炎的患者的剂量和施用 [P] . 中国专利： CN111278857A . 2020-06-12
• 2. 用于治疗阵发性睡眠性血红蛋白尿症(PNH)的抗C5抗体的皮下剂量和施用 [P] . 中国专利： CN112996561A . 2021-06-18
• 3. DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS [P] . 欧洲知识产权局专利： EP3692064A1 . 2020-08-12

  机译： 抗C5抗体的剂量和给药方式，用于治疗增生性肺结核患者

• 4. DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS [P] . 美国专利： US2020262897A1 . 2020-08-20

  机译： 抗C5抗体的剂量和给药方式，用于治疗增生性肺结核患者

• 5. Dosage and administration of anti-C5 antibodies for treatment of patients with Membranoproliferative glomerulonephritis [P] . AU2018345625A1 . 2020-04-16

  机译： 抗C5抗体的剂量和给药方式用于治疗膜增生性肾小球肾炎

• 1. Ziprasidone,haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia:A network metaanalysis [J] . Liang Su, Zheng Lu, Shenxun Shi, 综合精神医学（英文） . 2018,第005期
• 2. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents [J] . Giovanni Garini, Landino Allegri, Maria Luisa Carnevali, Nephrology Dialysis Transplantation . 2006,第11期
• 3. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents [J] . Giovanni Garini, Landino Allegri, Maria Luisa Carnevali, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2006,第11期
• 4. High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis (letter) [J] . Ohsawa I, Ohi H, Endo M, Nephron . 1999,第4期
• 5. Lack of response to classic treatment is associated with anti-cyclic citrullinated peptide antibodies but not with drb1-se status in patients with recent-onset rheumatoid arthritis [C] . Manzanares B., Martinez F., Gonzalez R., European Congress of Immunology . 2009
• 6. Anti-glomerular basement membrane glomerulonephritis: Characterization of an epitope, antibody response, and the potential role of IL-4Ralpha in disease progression. [D] . Robertson, Julie Milayna. 2009
• 7. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report [O] . Ayumu Takeno, Masahiro Yamamoto, Masakazu Notsu, 2016
• 8. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report [O] . 2016

• 1. Differential Treatment for Membranoproliferative Glomerulonephritis with TCM Prescriptions Plus Triptoryph Tablets A Report of 30 Cases [J] . 鞠建伟 ,连业钦 ,薄守波 . 中医杂志：英文版 . 2003,第3期
• 2. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration [J] . Christine M Hunt ,Lauren A Beste ,Elliott Lowy . 世界胃肠病学杂志：英文版 . 2016,第19期
• 3. Reclassification of membranoproliferative glomerulonephritis:Identification of a new GN:C3GN [J] . Maurizio Salvadori ,Giuseppina Rosso . 世界肾病学杂志：英文版 . 2016,第4期
• 4. Safety and Efficacy of Once-Daily Administration of Mycophenolate Mofetil in Kidney Transplant Patients—A New Treatment Option for Non-Adherence [J] . Naotsugu Ichimaru ,Kazuaki Yamanaka ,Taigo Kato . 生物医学工程（英文） . 2014,第10期
• 5. 一例病理类型由毛细血管壁内增生性肾小球肾炎转变为膜增生性肾小球肾炎的病例报道 [C] . 张宏博 ,黄建萍 ,都娟 . 中华医学会第十八次全国儿科学术会议 . 2013
• 6. 微针阵列给药技术用于增生性瘢痕治疗的研究 [A] . 于海 . 2013